Kezar Life Sciences, Inc. (KZR)

Kezar Life Sciences Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Kezar Life Sciences stock has a target of 9.00, which predicts an increase of 113.27% from the current stock price of 4.22.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$9.00	$9.00	$9.00	$9.00
Change	+113.27%	+113.27%	+113.27%	+113.27%

* Price targets were last updated on Dec 19, 2024.

Analyst Ratings

The average analyst rating for Kezar Life Sciences stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Derek Archila Wells Fargo	Wells Fargo	Hold Maintains $11 → $9	Hold	Maintains	$11 → $9	+113.27%	Dec 19, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Dec 2, 2024
Derek Archila Wells Fargo	Wells Fargo	Hold Maintains $20 → $11	Hold	Maintains	$20 → $11	+160.66%	Nov 14, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Oct 18, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Oct 14, 2024

More Analyst Ratings

Financial Forecast

• Revenue This Year:
  n/a
• Revenue Next Year:
  n/a
• EPS This Year:
  -9.21

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	7.00M	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-	-
EPS	-9.49	-10.35	-10.13	-14.04	-11.49	-9.21	-7.68	-7.54
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	6	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-7.27	-5.73	-3.09
Avg	-9.21	-7.68	-7.54
Low	-11.14	-12.01	-12.85

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.